Immutep Ltd Share Price Australian S.E.
Stocks
AU000000PRR9
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 6.78Cr 4.76Cr 4.13Cr 3.87Cr 3.54Cr 6.68Cr 453.32Cr 45Cr 18Cr 227.23Cr 18Cr 18Cr 754.77Cr | P/E 2026 * |
-1.19x | P/E 2027 * | -1.69x |
|---|---|---|---|---|---|
| Enterprise Value | 27.93L 19.63L 17.04L 15.93L 14.58L 27.51L 19Cr 1.87Cr 73.34L 9.36Cr 73.73L 72.13L 31Cr | EV / Sales 2026 * |
0.16x | EV / Sales 2027 * | -2.97x |
| Free-Float |
96.98% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +4.55% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 53 | 09/07/2014 |
David Fang
DFI | Director of Finance/CFO | - | 01/03/2018 |
Stephan Winckels
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Voigt
BRD | Director/Board Member | 53 | 09/07/2014 |
Russell Howard
CHM | Chairman | 76 | 17/11/2017 |
Pete Meyers
BRD | Director/Board Member | 57 | 12/02/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.55% | +4.17% | - | - | 4.89Cr | |
| +0.93% | -1.43% | +1.61% | +14.93% | 4.86TCr | |
| +0.26% | +9.34% | +415.26% | +533.80% | 4.19TCr | |
| -1.53% | -6.11% | +26.37% | +7.15% | 3.89TCr | |
| +0.69% | +0.79% | +7.35% | +63.05% | 3.72TCr | |
| +2.47% | +8.33% | +15.16% | +48.37% | 3.07TCr | |
| -0.47% | +0.01% | +34.08% | +126.09% | 1.64TCr | |
| +2.31% | -0.87% | - | - | 1.61TCr | |
| +0.29% | +1.81% | +4.92% | +18.60% | 1.4TCr | |
| -1.43% | -9.55% | -2.90% | -36.38% | 1.26TCr | |
| Average | +0.81% | -0.30% | +62.73% | +96.95% | 2.85TCr | |
| Weighted average by Cap. | +0.44% | +0.39% | +82.62% | +121.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.72Cr 1.21Cr 1.05Cr 98.31L 89.98L 1.7Cr 115.24Cr 12Cr 4.52Cr 58Cr 4.55Cr 4.45Cr 191.88Cr | 31.57L 22.18L 19.25L 18.01L 16.48L 31.09L 21Cr 2.11Cr 82.88L 11Cr 83.32L 81.51L 35Cr |
| Net income | -5.85Cr -4.11Cr -3.57Cr -3.34Cr -3.06Cr -5.76Cr -391.44Cr -39Cr -15Cr -196.21Cr -15Cr -15Cr -651.74Cr | -4.7Cr -3.31Cr -2.87Cr -2.68Cr -2.46Cr -4.63Cr -314.62Cr -31Cr -12Cr -157.71Cr -12Cr -12Cr -523.84Cr |
| Net Debt | -6.5Cr -4.57Cr -3.96Cr -3.71Cr -3.39Cr -6.4Cr -434.64Cr -43Cr -17Cr -217.87Cr -17Cr -17Cr -723.67Cr | -7.72Cr -5.42Cr -4.71Cr -4.4Cr -4.03Cr -7.6Cr -516.09Cr -52Cr -20Cr -258.7Cr -20Cr -20Cr -859.29Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
